Histamine receptors and their ligands: Mechanisms and applications

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 1149-1166

  Timmerman, H ^a   van der Goot, H ^a  

^a NONE

Author keywords

Allergy; Antihistamines; CNS diseases; Gastric disorders; Histamine; Histamine agonism; Histamine antagonism; Histamine inverse agonism; Histamine receptors; Inflammation; Research tools; Sedation; Side effects; Subclasses of histamine receptors

Indexed keywords

EID: 84882882289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.01149-9     Document Type: Chapter

References (14)

1. 3) of histamine receptor. Nature 1983, 302:832-837.
2. Back J.W., Duncan W.A.M., Durant G.J., et al. Definition and antagonism of histamine H2-receptor. Nature 1972, 236:385-390.
3. Cvetovic M., Leake B., From M.F. OATP and p-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metabolism and Disposition 1999, 27:866-871.
4. Hill J.S., Ganellin C.R., Timmerman H., et al. International Union of Pharmacology XIII. Classification of histamine receptors. Pharmacological Reviews 1997, 49:253-278.
5. 3 receptor. Progress in Medicinal Chemistry 2006, 44:181-206.
6. 3 Receptor; a Target for New Drugs 1998, Elsevier, Leiden-Amsterdam. R. Leurs, H. Timmerman (Eds.).
7. 4 receptor in anti-inflammatory therapy. Current Topics in Medicinal Chemistry 2006, 6:1365-1373.
8. 3 receptor. Molecular Pharmacology 1999, 55:1101-1107.
9. Oda T., Morikawa N., Saito Y., et al. Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. Journal of Biological Chemistry 2000, 275:36781-36786.
10. Smit M.J., Leurs R., Alewijnse A.E., et al. Inverse agonism of histamine H2 antagonists leads to antagonist-induced upregulation of the histamine H2 receptor. Proceedings of the National Academy of Sciences of the United States of America 1997, 93:6802-6807.
11. Tagliatela M., Timmerman H., Annunziata L. Cardiotoxic potential and CNS effects of first generation antihistamines. Trends in Pharmacological Science 2002, 21:52-56.
12. Timmerman H. Histamine H1 blockers: From relative failures to blockbusters within series of analogues. Analogue-based Drug Discovery 2006, 401-416. Wiley-VCH, Weinheim. J. Fischer, C.R. Ganellin (Eds.).
13. Van der Goot H., Timmerman H. Selective ligands as tools to study histamine receptors. European Journal of Medicinal Chemistry 2000, 35:5-20.
14. 3 receptor ligands break ground in a remarkable plethora of therapeutic areas. Expert Opinion on Investigational Drugs 2007, 16:967-985.